Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cognivia
Mont-Saint Guibert, Wallonia, Belgiumcognivia.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Cognivia has demonstrated that its platforms can reduce data variability by up to 30% in clinical trials, increase precision, predict patient dropout risk, and help control placebo response. Their solutions have been validated with real-world data from studies such as Type 1 Diabetes and Osteoarthritis, showing measurable improvements in trial outcomes.
- Therapeutic areas
- Other
- Modalities
- Digital tools for clinical trial optimization
- Industry
- Biomedical IT and Biomedical Data Platforms
Beyond the preview
Go deeper on Cognivia.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cognivia.